(S (NP (NP (JJ Recent) (NNS breakthroughs)) (PP (IN in) (NP (NN cancer) (NN research)))) (VP (VBP have) (VP (VBN come) (PP (IN via) (NP (NP (DT the) (JJ up-and-coming) (NN field)) (PP (IN of) (NP (JJ pathway) (NN analysis))))))) (. .))
(S (PP (IN By) (S (VP (VBG applying) (NP (JJ statistical) (NNS methods)) (PP (TO to) (NP (ADJP (VB prior) (VBN known)) (NN gene) (CC and) (VB protein) (JJ regulatory) (NN information)))))) (, ,) (NP (NN pathway) (NN analysis)) (VP (VBZ provides) (NP (NP (DT a) (JJ meaningful) (NN way)) (SBAR (S (VP (TO to) (VP (VB interpret) (NP (JJ genomic) (NNS data)))))))) (. .))
(SINV (SBAR (IN While) (S (NP (JJ many) (NNS gene/protein) (JJ regulatory) (NNS relationships)) (VP (VBP have) (VP (VBN been) (VP (VBN studied)))))) (, ,) (ADVP (RB never) (RB before)) (VBZ has) (NP (JJ such) (DT a) (JJ significant) (NN amount) (NNS data)) (VP (VBN been) (VP (VBN made) (S (ADJP (JJ available) (PP (IN in) (NP (NP (JJ organized) (NNS forms)) (PP (IN of) (NP (JJ gene/protein) (JJ regulatory) (NNS networks) (CC and) (NNS pathways))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (RB pathway) (NN analysis) (NN research)) (VP (VBZ is) (ADVP (RB still)) (PP (IN in) (NP (PRP$ its) (NN infancy))) (, ,) (SBAR (ADVP (RB especially)) (WRB when) (S (VP (VBG applying) (NP (PRP it)) (S (VP (TO to) (VP (VB solve) (NP (JJ practical) (NNS problems))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBP propose) (NP (NP (NP (DT a) (JJ new) (NN method)) (PP (IN of) (S (VP (VBG studying) (NP (JJ biological) (NNS pathways)))))) (, ,) (NP (NP (CD one)) (SBAR (WHNP (WDT that)) (S (VP (ADVP (NN cross)) (VBZ analyzes) (NP (NP (NN mutation) (NN information)) (, ,) (NP (NN transcriptome) (CC and) (NNS proteomics) (NNS data))))))))) (. .))
(S (S (VP (VBG Using) (NP (DT this) (NN outcome)))) (, ,) (NP (PRP we)) (VP (VBP identify) (NP (NP (NP (NNS routes)) (PP (IN of) (NP (JJ aberrant) (NNS pathways)))) (ADJP (RB potentially) (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN etiology)) (PP (IN of) (NP (NN disease)))))))) (. .))
(S (NP (DT Each) (NN pathway) (NN route)) (VP (VBZ is) (VP (VBN encoded) (PP (IN as) (NP (NP (DT a) (NN bayesian) (NN network)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN initialized) (PP (IN with) (NP (NP (DT a) (NN sequence)) (PP (IN of) (NP (JJ conditional) (NNS probabilities))) (VP (ADVP (RB specifically)) (VBN designed) (S (VP (TO to) (VP (VB encode) (NP (NP (NN directionality)) (PP (IN of) (NP (NP (JJ regulatory) (NNS relationships)) (VP (VBN encoded) (PP (IN in) (NP (DT the) (NNS pathways))))))))))))))))))))) (. .))
(S (NP (NP (ADJP (ADVP (RB Far) (RBR more)) (JJ complex)) (NNS interactions)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN phosphorylation) (CC and) (NN methylation)) (, ,) (PP (IN among) (NP (NNS others))) (, ,))) (PP (IN in) (NP (DT the) (NNS pathways)))) (VP (MD can) (VP (VB be) (VP (VBN modeled) (S (VP (VBG using) (NP (DT this) (NN approach))))))) (. .))
(S (NP (NP (DT The) (NN effectiveness)) (PP (IN of) (NP (PRP$ our) (NN model)))) (VP (VBZ is) (VP (VBN demonstrated) (PP (IN through) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB distinguish) (NP (JJ real) (NNS pathways)) (PP (IN from) (NP (NP (NNS decoys)) (PP (IN on) (NP (NP (NNP TCGA) (NN mRNA-seq)) (, ,) (NP (NN mutation)) (, ,) (NP (NNP Copy) (NNP Number) (NNP Variation)) (CC and) (NP (NN phosphorylation) (NNS data)))))) (PP (IN for) (NP (DT both) (NP (NNP Breast) (NN cancer)) (CC and) (NP (JJ Ovarian) (NN cancer) (NN study))))))))))) (. .))
(S (NP (NP (DT The) (NN majority)) (PP (IN of) (NP (NP (NNS pathways)) (VP (VBN distinguished))))) (VP (MD can) (VP (VB be) (VP (VBN confirmed) (PP (IN by) (NP (JJ biological) (NN literature)))))) (. .))
(S (ADVP (RB Consequently)) (, ,) (NP (NP (JJ such) (DT an) (JJ in-depth) (NN pathway) (NN analysis)) (VP (VBG incorporating) (NP (ADJP (JJR more) (JJ diverse)) (NNS data)))) (VP (MD can) (VP (VB give) (NP (NN rise)) (PP (TO to) (NP (NP (DT the) (NN accuracy)) (PP (IN of) (NP (JJ perturbed) (JJ pathway) (NN detection))))))) (. .))
